Similar articles

• Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.

  Prévost S, Boucher L, Larivée P, Boileau R, Bénard F. Prévost S, et al. J Nucl Med. 2006 Apr;47(4):559-65. J Nucl Med. 2006. PMID: 16595487
• Correlation of Glut-1 glucose transporter expression with.

  Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I. Higashi K, et al. Eur J Nucl Med. 2000 Dec;27(12):1778-85. Eur J Nucl Med. 2000. PMID: 11189940
• Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.

  Dooms C, Vansteenkiste J. Dooms C, et al. J Thorac Oncol. 2010 May;5(5):583-4. doi: 10.1097/JTO.0b013e3181d95cc8. J Thorac Oncol. 2010. PMID: 20421763 No abstract available.
• [Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].

  Vaylet F, Rivière F, Le Floch H, Bonnichon A, Mairovitz A, Staub E, Bonardel G, Margery J, Mantzarides M, Marotel C, Foehrenbach H. Vaylet F, et al. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S35-9. Rev Mal Respir. 2007. PMID: 18235392 Review. French.
• 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

  Laking G, Price P. Laking G, et al. Thorax. 2001 Sep;56 Suppl 2(Suppl 2):ii38-44. Thorax. 2001. PMID: 11514705 Free PMC article. Review. No abstract available.